Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
